Patents by Inventor Alfred F. ALTOMARI

Alfred F. ALTOMARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180325916
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: July 25, 2018
    Publication date: November 15, 2018
    Applicant: Agile Therapeutics, Inc.
    Inventors: Charles G. ARNOLD, Agis Kydonieus, Thomas M. Rossi, Alfred F. Altomari
  • Publication number: 20160250226
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: May 11, 2016
    Publication date: September 1, 2016
    Applicant: Agile Therapeutics, Inc.
    Inventors: Charles G. ARNOLD, Agis KYDONIEUS, Thomas M. ROSSI, Alfred F. ALTOMARI
  • Patent number: 9364487
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: June 14, 2016
    Assignee: Agile Therapeutics, Inc.
    Inventors: Charles G. Arnold, Agis Kydonieus, Thomas M. Rossi, Alfred F. Altomari
  • Publication number: 20130116222
    Abstract: A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 9, 2013
    Inventors: Charles G. ARNOLD, Agis KYDONIEUS, Thomas M. ROSSI, Alfred F. ALTOMARI